Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 30, 2015 5:24 PM ET


Company Overview of Stemedica Cell Technologies, Inc.

Company Overview

Stemedica Cell Technologies, Inc., a biopharmaceutical company, engages in the development and manufacture of adult stem cells and stem cell factors for research institutions and hospitals for pre-clinical and clinical studies. The company was incorporated in 2005 and is based in San Diego, California with a subsidiary location in Lausanne, Switzerland.

5375 Mira Sorrento Place

Suite 100

San Diego, CA 92121

United States

Founded in 2005





Key Executives for Stemedica Cell Technologies, Inc.

Vice Chairman and Chief Executive Officer
Age: 67
President, Chief Medical Officer and Director
Executive Chairman
Age: 67
Chief Financial Officer
Age: 66
Chief Regulatory & Clinical Development Officer
Compensation as of Fiscal Year 2014.

Stemedica Cell Technologies, Inc. Key Developments

Stemedica Cell Technologies, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-14-2015 03:00 PM

Stemedica Cell Technologies, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-14-2015 03:00 PM. Venue: Westin Grand Central Hotel, New York, New York, United States.

Stemedica Cell Technologies Appoints Mahendra Rao to its Scientific and Medical Advisory Board

Stemedica Cell Technologies Inc. welcomed to its Scientific and Medical Advisory Board prominent stem cell and regenerative medicine expert Dr. Mahendra Rao, M.D., Ph.D. As a Founding Director of the National Institute of Health (NIH) Center for Regenerative Medicine (CRM), he has built the Center into a world-class organization recognized for its excellence in the clinical translation of stem cell technology, and his expertise will help Stemedica shape its strategy to meet global demand for its stem cell technology.

Stemedica Cell Technologies, Inc. Appoints Craig W. Carlson as Chief Financial Officer, Effective March, 2014

Stemedica Cell Technologies, Inc. announced that Craig W. Carlson has been appointed the company's Chief Financial Officer effective March, 2014. Craig Carlson brings 34 years of financial, accounting, investor relations, and operational experience specifically in the biotech and biopharmaceutical industries to his role at Stemedica.

Similar Private Companies By Industry

Company Name Region
Beeologics, LLC United States
IROA Technologies LLC United States
Advanced Inhalation Research, Inc. United States
Embryo Armor Technologies, LLC United States
Pioneer Surgical Orthobiologics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Stemedica Cell Technologies, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at